Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Overall survival · people with metastatic CRC

Irinotecan‐based regimens showed no clear difference in overall survival compared with irinotecan (low certainty).

1 finding from 1 review

Second‐line systemic therapy for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
HR 0.91 [0.79, 1.04]
6 studies · 2615 participants
Low